Kaneka Europe Holding Company N.V. made an offer to acquire remaining 33.67% stake in AB-Biotics, S.A. (BME:ABB) for €21.2 million on September 3, 2019. Under the terms of the offer, Kaneka will pay €5 per share. The offeror holds a strong financial position and will meet the payment of the offer price with funds obtained from external financing. The deal is subject to AB-Biotics, S.A. shareholder approval. On October 4, 2019, deal is approved by shareholders of AB-Biotics, S.A. The period for the acceptance of the Offer will start from October 7, 2019 and will expire on November 7, 2019. EBN Banco de Negocios, S.A. acted as financial advisor for Kaneka Europe Holding Company N.V. Ernst & Young Servicios Corporativos, S.L provided fairness opinion for Board of Directors of AB-Biotics, S.A.